256 related articles for article (PubMed ID: 12544774)
1. Development of disease-specific health-related quality-of-life instruments for children with immune thrombocytopenic purpura and their parents.
Barnard D; Woloski M; Feeny D; McCusker P; Wu J; David M; Bussel J; Lusher J; Wakefield C; Henriques S; Blanchette V;
J Pediatr Hematol Oncol; 2003 Jan; 25(1):56-62. PubMed ID: 12544774
[TBL] [Abstract][Full Text] [Related]
2. Analysis of health-related quality of life in children with immune thrombocytopenia and their parents using the kids' ITP tools.
Zilber R; Bortz AP; Yacobovich J; Yaniv I; Tamary H
J Pediatr Hematol Oncol; 2012 Jan; 34(1):2-5. PubMed ID: 22215093
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in children with chronic immune thrombocytopenia in China.
Zhang H; Wang L; Quan M; Huang J; Wu P; Lu Q; Fang Y
Health Qual Life Outcomes; 2016 Mar; 14():45. PubMed ID: 26979950
[TBL] [Abstract][Full Text] [Related]
4. Validity, reliability, and responsiveness of a new measure of health-related quality of life in children with immune thrombocytopenic purpura: the Kids' ITP Tools.
Klaassen RJ; Blanchette VS; Barnard D; Wakefield CD; Curtis C; Bradley CS; Neufeld EJ; Buchanan GR; Silva MP; Chan AK; Young NL
J Pediatr; 2007 May; 150(5):510-5, 515.e1. PubMed ID: 17452226
[TBL] [Abstract][Full Text] [Related]
5. A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial.
Mathias SD; Bussel JB; George JN; McMillan R; Okano GJ; Nichol JL
Clin Ther; 2007 May; 29(5):950-962. PubMed ID: 17697914
[TBL] [Abstract][Full Text] [Related]
6. Development of a disease-specific quality of life questionnaire for children & adolescents with idiopathic thrombocytopenic purpura (ITP-QoL).
von Mackensen S; Nilsson C; Jankovic M; Mirra N; D'Angelo E; Borkhardt A; Ljung R
Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):688-91. PubMed ID: 16933256
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
Watts RG
Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
[TBL] [Abstract][Full Text] [Related]
8. Self-reported diagnostic and management strategies in childhood idiopathic thrombocytopenic purpura: results of a survey of practicing pediatric hematology/oncology specialists.
Vesely S; Buchanan GR; Cohen A; Raskob G; George J
J Pediatr Hematol Oncol; 2000; 22(1):55-61. PubMed ID: 10695823
[TBL] [Abstract][Full Text] [Related]
9. Treatment of immune thrombocytopenic purpura in children : current concepts.
Shad AT; Gonzalez CE; Sandler SG
Paediatr Drugs; 2005; 7(5):325-36. PubMed ID: 16220997
[TBL] [Abstract][Full Text] [Related]
10. Patterns and influences in health-related quality of life in children with immune thrombocytopenia: A study from the Dallas ITP Cohort.
Flores A; Klaassen RJ; Buchanan GR; Neunert CE
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28111877
[TBL] [Abstract][Full Text] [Related]
11. Silent bleeding in children and adolescents with immune thrombocytopenia: relation to laboratory parameters and health related quality of life.
Tantawy AA; Elsherif NHK; Kenny MA; Aboulfotouh KA; Hassan AE; Kabil ME
J Thromb Thrombolysis; 2020 Aug; 50(2):258-266. PubMed ID: 31956939
[TBL] [Abstract][Full Text] [Related]
12. Relationships among bleeding severity, health-related quality of life, and platelet count in children with immune thrombocytopenic purpura.
Neunert CE; Buchanan GR; Blanchette V; Barnard D; Young NL; Curtis C; Klaassen RJ
Pediatr Blood Cancer; 2009 Oct; 53(4):652-4. PubMed ID: 19492316
[TBL] [Abstract][Full Text] [Related]
13. The nontreatment of childhood ITP (or "the art of medicine consists of amusing the patient until nature cures the disease").
Bolton-Maggs PH; Dickerhoff R; Vora AJ
Semin Thromb Hemost; 2001 Jun; 27(3):269-75. PubMed ID: 11446660
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life of Egyptian children with immune thrombocytopenia and their parents.
Mokhtar GM; Farid SM; Shaker NM; Farrag KE
J Pediatr Hematol Oncol; 2014 Apr; 36(3):194-9. PubMed ID: 24322497
[TBL] [Abstract][Full Text] [Related]
15. Current challenges in the management of children with idiopathic thrombocytopenic purpura.
Buchanan GR; Adix L
Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):681-4. PubMed ID: 16933253
[TBL] [Abstract][Full Text] [Related]
16. Acute childhood idiopathic thrombocytopenic purpura: AIEOP consensus guidelines for diagnosis and treatment. Associazione Italiana di Ematologia e Oncologia Pediatrica.
De Mattia D; Del Principe D; Del Vecchio GC; Jankovic M; Arrighini A; Giordano P; Menichelli A; Mori P; Zecca M; Pession A
Haematologica; 2000 Apr; 85(4):420-4. PubMed ID: 10756369
[TBL] [Abstract][Full Text] [Related]
17. Age and duration of bleeding symptoms at diagnosis best predict resolution of childhood immune thrombocytopenia at 3, 6, and 12 months.
Revel-Vilk S; Yacobovich J; Frank S; Ben-Ami T; Yechieli M; Shkalim V; Lebel A; Semo-Oz R; Tamary H
J Pediatr; 2013 Nov; 163(5):1335-9.e1-2. PubMed ID: 23891349
[TBL] [Abstract][Full Text] [Related]
18. Pilot study of the effect of romiplostim on child health-related quality of life (HRQoL) and parental burden in immune thrombocytopenia (ITP).
Klaassen RJ; Mathias SD; Buchanan G; Bussel J; Deuson R; Young NL; Collier A; Bomgaars L; Blanchette V
Pediatr Blood Cancer; 2012 Mar; 58(3):395-8. PubMed ID: 21910213
[TBL] [Abstract][Full Text] [Related]
19. Sports Participation in Children and Adolescents with Immune Thrombocytopenia (ITP).
Kumar M; Lambert MP; Breakey V; Buchanan GR; Neier M; Neufeld EJ; Kempert P; Neunert CE; Nottage K; Klaassen RJ;
Pediatr Blood Cancer; 2015 Dec; 62(12):2223-5. PubMed ID: 26174203
[TBL] [Abstract][Full Text] [Related]
20. Outcome measures and treatment endpoints other than platelet count in childhood idiopathic thrombocytopenic purpura.
Buchanan GR; Adix L
Semin Thromb Hemost; 2001 Jun; 27(3):277-85. PubMed ID: 11446661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
